Leap Therapeutics, Inc. (LPTX) Misses Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts LPTX Hot Sheet
Join SI Premium – FREE
Leap Therapeutics, Inc. (NASDAQ: LPTX) reported Q2 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Leap Therapeutics, Inc. (LPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
